Latest News in the pharma Industry

Top Stories

Pharmaceutical companies increase outsourcing

Pharmaceutical companies increase outsourcing

10 Jan 2013

Number of pharmaceutical companies using outsourcing increases.

Read more 
Brain tumour investment 'lagging'

Brain tumour investment 'lagging'

7 Jan 2013

Funding for research and treatment of brain tumours is 'lagging behind' other cancers, says a charity.

Read more 
South Korea set for global biosimilars leadership

South Korea set for global biosimilars leadership

7 Jan 2013

A Frost & Sullivan report has predicted significant growth in the South Korean biosimilars market between now and 2020.

Read more 
Pfizer Licenses Quinazoline Drug Program

Pfizer Licenses Quinazoline Drug Program

5 Jan 2013

Repligen Corp. has entered into an exclusive worldwide licensing agreement with Pfizer to advance its spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).

Read more 
Tranzyme, BMS Complete Drug Pact

Tranzyme, BMS Complete Drug Pact

5 Jan 2013

Tranzyme Pharma has successfully completed its chemistry-based drug discovery collaboration with Bristol-Myers Squibb and has transferred compounds, across multiple drug targets, to BMS for further development.

Read more 
Israeli pharma market 'worth $2.3 billion by 2020'

Israeli pharma market 'worth $2.3 billion by 2020'

25 Dec 2012

GlobalData's latest report looks at the prospects for the pharmaceutical industry in Israel.

Read more 
Chinese pharmaceutical market to enjoy 'dramatic' growth

Chinese pharmaceutical market to enjoy 'dramatic' growth

25 Dec 2012

A new report looks at the potential for growth in the Chinese pharmaceutical market.

Read more 
GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique

GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique

19 Dec 2012

GSK has formed a partnership with Vodafone to harness innovative mobile technology to help vaccinate more children against common infectious diseases in Africa.

Read more 
Epilepsy drug market to reach nearly $3.7bn by 2016

Epilepsy drug market to reach nearly $3.7bn by 2016

16 Dec 2012

Decision Resources has published its latest predictions for the epilepsy drug market through 2021.

Read more 
Next Generation Sequencing of GATC Biotech AG Accredited by German DAkkS

Next Generation Sequencing of GATC Biotech AG Accredited by German DAkkS

5 Dec 2012

GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation

Read more 
Health economics and outcomes research 'increasingly important to pharma'

Health economics and outcomes research 'increasingly important to pharma'

3 Dec 2012

A new report suggests that more and more pharmaceutical companies are devoting dedicated budgets to health economics and outcomes research.

Read more 
Ranbaxy Begins Atorvastatin Recall

Ranbaxy Begins Atorvastatin Recall

30 Nov 2012

Ranbaxy, Inc., a subsidiary of India’s Ranbaxy Laboratories Ltd., has initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium tablets (10 mg, 20 mg and 40 mg), a generic of Pfizer’s Lipitor.

Read more